» Articles » PMID: 39730103

A Comprehensive Review of Massive Transfusion and Major Hemorrhage Protocols: Origins, Core Principles and Practical Implementation

Overview
Specialty Anesthesiology
Date 2024 Dec 27
PMID 39730103
Authors
Affiliations
Soon will be listed here.
Abstract

Until the beginning of the century, bleeding management was similar in elective surgeries or exsanguination scenarios: clotting tests were used to guide blood product orders and, while awaiting these results, an aggressive resuscitation with crystalloids was recommended. The high mortality rate in severe hemorrhages managed with this strategy endorsed the need for a special resuscitation plan. As a result, modifications were recommended to develop a new clinical approach to these patients, called "Damage Control Resuscitation". This strategy includes four principles: damage control surgery, minimization of crystalloids, permissive hypotension and hemostatic resuscitation. The latter involves the use of antifibrinolytics, correction of preconditions of hemostasis (calcium, pH and temperature) and the early and rapid restoration of intravascular volume with blood products. To enable timely availability and transfusion of blood products, specific actions in different hospital areas need to be synchronized, which are usually organized through Massive Transfusion Protocols or, as they have recently been rebranded, Major Hemorrhage Protocols (MHPs). Although these bundles of actions represent a paradigm change, essential aspects such as their historical evolution, theoretical foundations, terminology and operational elements have yet to be well explored. Considering the wide application range of these tools (emergency departments, interventional radiology, operating rooms and military fields), it is essential to integrate all professionals involved with severe hemorrhage scenarios in the implementation of the aforementioned protocols, from conception to execution and management. This review paper addresses MHP aspects relevant to anesthesiologists, transfusion services and other areas involved with the care of patients with severe bleeding.

References
1.
Rossaint R, Afshari A, Bouillon B, Cerny V, Cimpoesu D, Curry N . The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition. Crit Care. 2023; 27(1):80. PMC: 9977110. DOI: 10.1186/s13054-023-04327-7. View

2.
Nunez T, Voskresensky I, Dossett L, Shinall R, Dutton W, Cotton B . Early prediction of massive transfusion in trauma: simple as ABC (assessment of blood consumption)?. J Trauma. 2009; 66(2):346-52. DOI: 10.1097/TA.0b013e3181961c35. View

3.
Safiejko K, Smereka J, Filipiak K, Szarpak A, Dabrowski M, Ladny J . Effectiveness and safety of hypotension fluid resuscitation in traumatic hemorrhagic shock: A systematic review and meta-analysis of randomized controlled trials. Cardiol J. 2020; 29(3):463-471. PMC: 9170316. DOI: 10.5603/CJ.a2020.0096. View

4.
Hess J, Holcomb J, Hoyt D . Damage control resuscitation: the need for specific blood products to treat the coagulopathy of trauma. Transfusion. 2006; 46(5):685-6. DOI: 10.1111/j.1537-2995.2006.00816.x. View

5.
Agaronov M, DiBattista A, Christenson E, Miller-Murphy R, Strauss D, Shaz B . Perception of low-titer group A plasma and potential barriers to using this product: A blood center's experience serving community and academic hospitals. Transfus Apher Sci. 2016; 55(1):141-5. DOI: 10.1016/j.transci.2016.05.018. View